Skip to content
Actipulse Neuroscience logo

Actipulse Neuroscience

Actipulse Neuroscience is a YC Winter 2022 (W22) company. Based in Cambridge, MA, USA; Mexico City, CDMX, Mexico. Team of 38.

  • Mental Health Tech
  • Neurotechnology
  • Medical Devices

About Actipulse Neuroscience

GPAgent's own fund-neutral profile, written from public information. Updated Oct 5, 2026.

Summary

Actipulse Neuroscience builds a proprietary non-invasive brain stimulation device that lets patients with Major Depressive Disorder receive treatment at home rather than in a hospital. The device uses high-frequency magnetic pulses to deliver transcranial neuromodulation, replacing clinic-based sessions that are expensive and logistically burdensome. The company is advancing the same technology into pilot studies for Alzheimer's and Parkinson's disease.

From the Y Combinator listing

How Actipulse Neuroscience describes itself in Y Combinator's public directory. Original listing (opens in a new tab)

Bringing non-invasive brain stimulation from the hospital to the home

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.

Facts

Industry
Healthcare / Healthcare -> Medical Devices
Location
Cambridge, MA, USA; Mexico City, CDMX, Mexico
Team size
38
Status
Active
Stage
Early

Founders (2)

Score every batch against your own thesis

GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.

How Accelerator intelligence works